CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net income	$ 151,164	$ 135,884	$ 151,419
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation	153,825	141,456	113,265
Net amortization of debt discounts, premiums and deferred financing fees	6,042	5,327	5,067
Straight line rental income	(7,080)	(13,849)	(11,457)
Amortization of acquired real estate leases and other intangible assets	3,656	1,597	(93)
Loss on early extinguishment of debt	797	6,349	427
Impairment of assets	45,599	3,071	1,990
Gain on lease terminations		(375)
(Gain) loss on sale of properties	(37,392)	101	(21,315)
Equity in (earnings) losses of an investee	(334)	(316)	(139)
Change in assets and liabilities:
Restricted cash	(3,082)	(2,304)	(2,134)
Other assets	(11,051)	991	(7,341)
Accrued interest	82	(6,524)	7,288
Other liabilities	4,477	11,894	17,259
Cash provided by operating activities	306,703	283,302	254,236
Cash flows from investing activities:
Real estate acquisitions and deposits	(193,303)	(316,769)	(797,113)
Real estate improvements	(52,270)	(50,131)	(39,309)
Loan receivable			(80,000)
Principal payments on loan receivable		38,000	42,000
Investment in Five Star Quality Care, Inc.			(5,000)
Proceeds from sale of properties	92,550	1,041	38,663
Cash used for investing activities	(153,023)	(327,859)	(840,759)
Cash flows from financing activities:
Proceeds from issuance of common shares, net	261,813	287,052	432,233
Proceeds from issuance of unsecured senior notes, net of discount		350,000	541,984
Proceeds from borrowings on revolving credit facility	275,000	669,000	690,000
Repayments of borrowings on revolving credit facility	(365,000)	(479,000)	(818,000)
Redemption of senior notes		(225,000)
Repayment of other debt	(36,371)	(266,528)	(9,711)
Payment of deferred financing fees	(3,326)	(12,608)	(13,760)
Distributions to shareholders	(288,945)	(259,537)	(223,529)
Cash (used for) provided by financing activities	(156,829)	63,379	599,217
(Decrease) increase in cash and cash equivalents	(3,149)	18,822	12,694
Cash and cash equivalents at beginning of period	42,382	23,560	10,866
Cash and cash equivalents at end of period	39,233	42,382	23,560
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	111,695	118,437	85,907
Income taxes paid	600	389	264
NON-CASH INVESTING ACTIVITIES:
Acquisitions funded by assumed debt	(12,266)	(121,793)	(217,317)
NON-CASH FINANCING ACTIVITIES:
Assumption of mortgage notes payable	12,266	121,793	217,317
Issuance of common shares	$ 2,541	$ 2,229	$ 1,814

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) and liabilities in a systematic and rational manner to the periods expected to be impacted from such assets and liabilities. As a noncash expense/ income, this element is added back to/deducted from net income when calculating cash provided by (used in) operations using the indirect method.

No definition available.